Black Widow Spider Antivenin

· Instituto Bioclon S.A. de C.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Black Widow Spider Antivenin, covering 2017-09-18 to 2017-09-18. Get the full timeline:

Most recent: Clinical Trial Update: Black Widow Spider Antivenin for Patients With Systemic Latrodectism [Phase 3]